Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Hosp Palliat Care. 2007 Apr-May;24(2):126-30.

On how increasing numbers of newer cancer therapies further delay referral to hospice: the increasing palliative care imperative.

Author information

1
Pain and Supportive Care Program, Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, Pennsylvania, USA. dmmonc@aol.com

Abstract

Delay in referral of cancer patients to hospice until very near the end of life may deny patients and families optimal palliative care. A variety of factors may contribute to these delays. This article describes how the proliferation of newer anticancer therapies, although desirable overall, may further increase these delays. It is important for hospice personnel to understand these changes in medical oncology and to work to optimize palliative care delivery concomitantly with disease-remitting therapies.

PMID:
17502437
DOI:
10.1177/1049909106297363
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center